13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 30
2025-03-31 $3.54B
Positions 49
Showing 7 of 7 rows (filtered from 56)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 BRIDGEBIO PHARMA INC $0 0 -1,023,950 -100.00% 0.97%
2 DADA NEXUS LTD $0 0 -700,000 -100.00% 0.03%
3 GE VERNOVA INC $0 0 -7,826 -100.00% 0.09%
4 HELLO GROUP INC $0 0 -53,590 -100.00% 0.01%
5 KINIKSA PHARMACEUTICALS INTL $0 0 -1,582,635 -100.00% 1.08%
6 PYXIS ONCOLOGY INC $0 0 -382,606 -100.00% 0.02%
7 TRANE TECHNOLOGIES PLC $0 0 -2,338 -100.00% 0.03%